ALB and hepatocellular carcinoma: However, validated tools for predicting TO specifically for patients with hepatocellular carcinoma (HCC) undergoing hepatectomy within an Enhanced Recovery After Surgery (ERAS) pathway remain scarce, particularly models integrating the albumin-bilirubin (ALBI) grade.<h4>Methods</h4>We conducted a single-center retrospective analysis of 685 consecutive patients who underwent curative hepatectomy for HCC between January 2021 and December 2025.